Professional Documents
Culture Documents
Evaluate LVH With CMR in HTN
Evaluate LVH With CMR in HTN
Evaluate LVH With CMR in HTN
CMR in Hypertension
Neurohormonal
Sympathetic
Inflammatory
Transition Point ??
• Provide early clues for LVH, associated • First line imaging in assessing hypertensive
structural/electrical abnormalities heart disease
• Lacks sensitivity and specificity • Assessing morphology and cardiac function
(systolic/diastolic)
• Linear measurements to estimate volumes
Assessment of LV Mass
*Hypertension 2002;39:750-755
Diagnosis of LVH
Myocardial
Non ischemic
ECV
LGE
Map
Myocardial Fibrosis a Marker of Adverse Prognosis in Patients with Hypertension
Hypertension 2022;79;1804
Is Myocardial Fibrosis Reversible?
NCT03553810
Entresto Valsartan
1 year study to investigate the potential role of medications to regress fibrosis on CMR
• Accurate assessment of LVH is crucial
for the diagnosis and progression of
hypertensive heart disease
• Identifying the transition point from
adaptation and decompensation
improves risk stratification and
targeted therapies
• LV Geometric Patterns
• LV function
• Myocardial fibrosis